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Abstract
Background Recent studies suggest that postnatal weight
gain can play an important role in the development of
retinopathy of prematurity (ROP).
Aim To analyze the low weight gain (WG) from birth to
6 weeks of life to predict the development of severe
retinopathy of prematurity (ROP) among very low birth
weight preterm babies (VLBW).
Methods A prospective cohort study included 317
newborns with birth weight (BW) ≤1,500 g and gestational
age (GA) ≤32 weeks. The main outcome was the
development of severe ROP (defined as threshold ROP
and higher stages of ROP). In all patients, the proportion of
the WG was defined as the preterm weight measured at
6 weeks of life minus the BW divided by the BW.
Seventeen risk factors for ROP were studied by univariate
analysis. Chi-square test and Student’s t-test were used to
compare no-ROP/mild ROP patients and severe ROP
patients. Logistic regression and receiver operating charac-
teristic (ROC) curve were used to determine if the WG
proportion was independently related to severe ROP
development and if it was capable of predicting severe
ROP. Ophthalmological examinations started between the
fourth and sixth week of life, and were repeated until the
45th week of postmenstrual age. Weight gain proportion
was always calculated at completed 6 weeks of life.
Results Mean GA and mean BW of the whole cohort were
29.6 weeks (±1.9) and 1,124 grams (±239.5) respectively.
After logistic regression, the low WG proportion under
51.2% from the BW, measured at 6 weeks of life, showed
OR 3.007 (95%CI: 1.195-7.566; P=0.019), for severe ROP,
when adjusted for BW and for any stage intraventricular
hemorrhage. Area under the ROC curve was 0.63 (95%CI:
0.495-0.761;P=0.037). For the discriminative cutoff of 51.2%
of the WG proportion, sensitivity and specificity values were
66.3% and 62.6% respectively. Positive and negative predic-
tive values were 10.2% and 94.7% respectively.
Conclusions Low WG by six weeks of life is an important
and independent risk factor for severe ROP and is capable
to predict the development of severe ROP in most patients
that needed treatment.
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Introduction
Retinopathy of prematurity (ROP) is an important compli-
cation of preterm newborns. ROP was first described in
1942, and quickly became a leading cause of childhood
blindness in industrialized countries [1]. Recently, ROP has
been also identified as one of the most important causes of
treatable blindness among children in many countries in
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Latin America, China and India and among the former
emerging economies from East Europe, due to the increase
in the survival rates among preterm newborns [2, 3].
ROP is a multifactorial disease, and the main postnatal
risk factors described are oxygen-therapy, low gestational
age (GA), low birth weight (BW), sepsis, intraventricular
hemorrhage, blood transfusion, and use of indomethacin,
surfactant and erythropoietin [4–6].
Postnatal low weight gain (WG) of very low birth weight
(VLBW) infants is a recently mentioned risk factor for ROP
[7–9]. Only three previous studies, a retrospective [7], a
case-control [8], and a prospective cohort [9], reported the
association between postnatal low WG and occurrence of
ROP in VLBW premature infants. In the last of these
studies, Löfqvist et al. [9] demonstrated the usefulness of
the longitudinal postnatal WG and serum insulin-like
growth factor-I (IGF-I) measurements from birth until
postmenstrual age of 36 weeks to predict ROP. There is
no prospective study addressing only the importance of the
VLBW infants’ WG and the occurrence of severe ROP. In
the year 2002, we designed a prospective cohort study to
analyze if the WG from birth to 6 weeks of life could be an
independent risk factor for severe ROP and if it could
predict severe ROP, once the low postnatal WG is easily
identifiable as a risk factor, during the screening sessions to
detect ROP.
Methods
Patients
We performed a prospective cohort study analyzing the
prevalence of severe ROP from the initial ophthalmologic
examination up to the 45th week of postmenstrual age and the
WG proportion from birth up to 6 weeks of life. All preterm
neonates admitted to the Neonatal Intensive Care Unit (NICU)
of Hospital de Clínicas de Porto Alegre, Brazil from October
2002 to November 2007, with BW ≤1,500 grams and GA
≤32 weeks, were included. Infants that died before completing
6 weeks of life or before 45 weeks of postmenstrual age were
excluded. No other exclusion criteria were used. The
ophthalmic examination was always performed by the
same author (JBFF) and consisted of binocular indirect
ophthalmoscopy with a 28 D Nikon lens (Nikon®, Melville,
NY, USA) and the lid speculum for newborn (Alfonso Eye
Speculum, Storz®, Bausch & Lomb Inc., San Dimas, CA,
USA), after dilation of the pupils with eye drops containing
tropicamide 0.5% and phenylephrine 2.5%. Scleral indenta-
tion was used in order to achieve a better examination of the
peripheral zone III.
According to the Brazilian guidelines for ROP screen-
ing, all infants were first examined between 4 and 6 weeks
of life and then followed once or twice a week depending
on the severity of the disease or until retinal vascularization
was completed. All babies were allways examined in the
NICU while hospitalized, and as outpatients after discharge
up to completed 45 weeks of postmenstrual age.
Outcome and variables
The main clinical outcome was the occurrence of severe
ROP in either eye during the entire observational period.
The worst ROP stage, in either eye, was always recorded,
according to the International Classification of 1984/1987
[10, 11]. Severe ROP was defined as any ROP stage 3,
threshold disease, or more. Threshold disease was defined
according to the Multicenter Trial of Cryotherapy for ROP
[12]. The prevalence of ROP was calculated with 95%
confidence intervals.
The main variable was the WG proportion measured at
completed 6 weeks of life in relation to BW. It was
calculated as the baby’s weight measured at 6 weeks of life
minus the BW, divided by the BW, in all patients. Perinatal
variables considered for the study were the already
described risk factors for ROP: BW, GA, gender, use of
oxygen-therapy on mechanical ventilation or on nasal
Continuous positive airway pressure (CPAP), single or
multiple gestation, use of surfactant, indomethacin and
erythropoietin therapies, Apgar score at 5 minutes, sepsis,
meningitis, all intraventricular hemorrhage stages, blood
transfusions, persistent ductus arteriosus, weight at 6 weeks
of life, and the absolute WG at 6 weeks of life (defined as
the baby’s weight at completed 6 weeks of life minus the
BW). Those data were obtained prospectively.
Statistical methods and ethics
The chi-square test was used to compare no-ROP/mild ROP
patients and severe ROP patients. Student’s unpaired t-test
was used to compare continuous data. In the logistic
regression, the dependent variables were chosen by their
significance after univariate analysis. The main variable
(WG proportion from birth to the sixth week of life) was
included in the logistic regression as a continuous variable,
without cutoff points, as well as it was included with the
best discriminative sensibility/specificity value after the
ROC curve results as a cutoff point. Patients under this
cutoff point were classified as low WG patients. Odds ratio
(OR) was calculated and compared after adjustments in
both situations. Confidence interval 95% and significance
level of P<0.05 were recorded. Receiver operating charac-
teristic (ROC) curve was calculated for the proportional
WG and severe ROP development. Statistical analysis was
performed using the Statistical Package for Social Sciences
software (SPSS 14.0 for Windows, SPSS Inc., Chicago, IL,
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USA). The study protocol was approved by the Ethics
Committee of the HCPA.
Results
The prospective cohort comprised 317 neonates, of whom
183 (57.7%) were female and 63.7% were small for GA
(SGA <10 percentile) patients. Birth weight in all studied
newborns ranged from 505 to 1,500 grams, with a mean of
1,124 grams (SD 239.5). Gestational age ranged from 24 to
32 weeks, with a mean of 29.7 weeks (SD 1.9). Severe
ROP needing treatment occurred in 24 patients (7.2%),
among whom 23 achieved ROP stage 3, threshold disease
and were treated by transpupillary diode laser photocoag-
ulation. One patient reached ROP stage 4 despite two laser
treatments. Only one patient reached ROP stage 5 (0.3%)
by missing the scheduled treatment after NICU discharge,
and only one baby, born at 32 weeks GA and with BW of
1,315 grams, developed ROP (threshold disease) at post-
menstrual age of 41 weeks. This baby achieved 2,200 grams
by the sixth week of life (with 68% of the WG proportion,
as defined). The mean GA for pre-threshold ROP among
our patients was 36.3 (SD 1.6) weeks and for threshold
ROP was 37.9 (SD 1.7) weeks. The demographic character-
istics of all included patients, as well as the complete
prevalence of ROP, are displayed in Table 1.
In Table 2 we show the univariate comparison between
no-ROP/mild ROP and severe ROP patients: BW (P<
0.001), GA (P<0.001), weight at 6 weeks of life (P<
0.001), WG (P<0.001), WG proportion (P=0.019), and
any stage intraventricular hemorrhage (P=0.047) were
significantly lower in severe ROP patients.
After logistic regression, the WG proportion from birth
to the sixth week of life, adjusted for BW and for any stage
intraventricular hemorrhage, showed OR 3.007 (95%CI:
1.195-7.566; P=0.019) when considered the cutoff point
under 51.2% of the BW; and as a continuous variable,
without cutoff points, it showed OR 1.032 (95%CI: 1.008-
1.055; P=0.008), Table 3.
For severe ROP, the area under the ROC curve was 0.63
(95%CI: 0.495-0.761; P=0.037). For the best discriminative
cutoff of 51.2% of the proportional WG over the BW,
sensitivity and specificity values were 66.3% and 62.6%
respectively. Positive and negative predictive values were
10.2% (95%CI: 6.1-15.9%) and 94.7% (95%CI: 90.5-97.4%)
respectively.
Discussion
Our study showed that WG proportion under 51.2% from
birth to 6 weeks of life was an important and independent
risk factor for severe ROP, and was capable of predicting
the development of severe ROP needing treatment in the
group of VLBW preterm babies. Our results are also in
accordance with the longitudinal growth curves for hospi-
talized VLBW described by Ehrenkranz et al. [13] in 1999,
and widely used in modern neonatology, in which these
patients are expected to regain weight, around 50% of their
BW, after completed 6 weeks of life.
ROP pathogenesis is still incompletely understood. For
many years, the high oxygen levels administered to
neonates was considered the main risk factor for ROP
development [14]; however, the disease kept occurring
even after careful control in oxygen administration [15]. To
date, no absolutely safe level for oxygen use has been
demonstrated [16, 17]. In our institution, oxygen adminis-
tration is always monitored by pulse oxymetry, with
recommended saturation between 88-94%. The overall
incidence of ROP in our study was similar to other
published results [18–20].
The presence of any stage intraventricular hemorrhage
was significant as a risk factor for ROP in our cohort of
patients. Procianoy et al. [21], in 1981, related a significant
association between cicatricial ROP and intraventricular
hemorrhage in 138 VLBW. Christiansen et al. [22], in
2002, published a significant association between intraven-
tricular hemorrhage and ROP in 60 VLBW where neonates
with more severe intraventricular hemorrhage grades
reached severe ROP.
Low BW and GA have been implicated most directly in
ROP development [23–25], but low WG as an independent
risk factor for ROP development was just recently
Table 1 Prevalence of ROP and demographic characteristics of the
study population
Characteristic Value
Number of patients 317
No-ROP 219 (69.1%)
ROP 98 (30.9%)
ROP 1 42 (13.2%)
ROP 2 32 (10.1%)
ROP 3* 22 (6.9%)
ROP 4* 1 (0.3%)
ROP 5* 1 (0.3%)
Female gender 183 (57.7%)
SGA 202 (63.7%)
Mean BW (grams)** 1,124.0±239.5
Mean GA (weeks)** 29.6±1.9
Mean WG (grams)** 597.0±218.1
*: Severe ROP needing treatment; **: Data presented as mean ±
standard deviation; SGA: small for the gestational age (<10
percentile); BW: birth weight; GA: gestational age; WG: weight gain
from birth to the sixth week of life.
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described. Hall et al. [26], in 1995, related a low WG
associated with severity of ROP in four survivors in a birth
of quintuples with identical GA and similar BW. Homes
and Düffner [27], in 1996, demonstrated that rats submitted
to growth retardation developed retinal neovascularization
more frequently and more severely.
A retrospective study by Wallace et al. [7], published in
2000, analyzed postnatal WG and another 11 risk factors in
a group of 111 neonates. They suggested that WG under
50% of BW at 6 weeks of life indicated an important risk
for severe forms of ROP. According to Wallace et al., the
study results could not be explained by the difference in the
average BW among the patients with severe ROP and those
with less severe or no ROP, but by the difference in WG
proportion in the 6-week period after premature birth, and
they concluded that there was a significant difference in
WG in infants with severe and discrete or no ROP. Shaffer
et al. [28] previously claimed that the absolute ratio of WG
in VLBW would be proportional to the neonate’s BW, and
consequently, the expected proportion of WG should be the
same for preterm infants with different BW in the same
period of life.
Allegaert et al. [8], in 2003, in a prospective case-control
study registered perinatal growth characteristics of 31
neonates with ROP threshold disease and in 31 neonates
with the same GA who didn’t develop ROP. They
concluded that small for GA preterm newborns and those
with intrauterine growth restriction had an increased risk of
developing ROP threshold disease. In contrast, the relative
WG (grams/kg/day) was not significantly different in the
group with ROP and in the control group.
Recently, some studies showed the relation between the
insulin-like growth factor-I (IGF-I) and ROP development.
Hellström et al. [29] reported that in preterm infants with
the same GA, IGF-I serum levels during the postnatal
period were significantly and proportionally lower in those
that developed ROP than in the ones who did not. In 2006,
Löfqvist et al. [9] showed that weekly measurements of
postnatal WG together with a serum level of IGF-I were a
useful marker for the risk of severe ROP. In this article, the
authors disclosed some very important conclusions indicat-
ing the need to monitor the postnatal factors of weight,
IGF-I level and IGF binding protein 3 level in order to
enhance the clinician’s ability to identify patients who will
require treatment for ROP. Unfortunately, this approach
seems to have some difficulties of use among ophthalmol-
ogists during the screening sessions to detect ROP, mainly
in the middle-income countries context; once-weekly
Table 3 Odds ratio to develop severe ROP after logistic regression adjusted when a weight gain proportion is used as a continuous variable, and
the weight gain proportion under 51.2% of the birth weight, according to the ROC curve
OR 95% CI P
Continuous WG proportion (without cutoffs)* 1.032 1.008 - 1.055 0.008
Low WG proportion* (WG <51.2% of the BW) 3.007 1.195 - 7.566 0.019
WG: weight gain; *: adjusted for birth weight (BW) and for any stage intraventricular hemorrhage.
No-ROP/Mild-ROP patients
(n=293)
Severe ROP patients
(n=24)
P
Birth weight (grams) * 1,141.6±231.7 908.7±232.6 <0.001
Gestational age (weeks) * 29.8±1.8 27.9±2.2 <0.001
Weight at 6 weeks of life (grams) * 1,753.9±362.5 1,319.2±419.7 <0.001
Weight gain (grams) * 612.3±205.6 410.4±279.1 <0.001
Weight gain proportion (%)* 54.6±18.3 45,1±25.1 0.019
Apgar score at 5 minutes* 7.8±1.7 7.6±1.7 0.653
Use of oxygen on mechanical ventilation 152 (52.1%) 15 (62.5%) 0.397
Use of oxygen on nasal CPAP 230 (78.5%) 20 (83.3%) 0.795
Use of erythropoietin 231 (79.1%) 20 (83.3%) 0.819
Use of indomethacin 100 (34.1%) 9 (37.5%) 0.824
Any intraventricular hemorrhage stage 45 (15.4%) 8 (33.3%) 0.047
Blood transfusions 129 (44.0%) 14 (58.3%) 0.204
Use of surfactant 140 (47.8%) 14 (58.3%) 0.397
Multiple gestation 46 (15.7%) 4 (16.7%) 1.000
Sepsis 200 (68.3%) 19 (79.2%) 0.360
Meningitis 19 (6.5%) 3 (12.5%) 0.486
Persistent ductus arteriosus 40 (13.7%) 3 (12.5%) 1.000
Female gender 170 (58.0%) 13 (54.2%) 0.830
Table 2 Univariate analysis
of the risk factors for the
development of severe ROP
*Data presented in mean ±
standard deviation (Student’s
t-test); BW: birth weight; nasal
CPAP: nasal continuous posi-
tive airway pressure
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laboratory measurements of IGF-I and IGF binding protein
3 serum levels are cost expensive for national health care
systems, and also, these laboratory tools are not widely
available in most of the Latin American countries.
Engström et al. [30] related the role of maternal factors,
postnatal nutrition and the WG in regulation of serum IGF-I
among preterm infants. IGF-I is present in the natural
maternal milk, and so an adequate natural breast-feeding
could help in the prevention of ROP.
A question beyond the scope of our study is about why
these babies are poor at gaining weight. The most practical
answer to this question could be because they are sicker
babies; but once we know about low WG as a risk factor for
ROP, it is possible to follow-up these babies closely before
the development of treatable ROP, trying to improve their
clinical conditions. According to Ehrenkranz et al. [13], the
WG after the second week of life is related to the nutritional
support, and healthier babies usually gain weight faster than
sicker babies. The low WG in the postnatal period could be
indicative for the development of general morbidities, some
of them also related with ROP development, such as sepsis,
intraventricular hemorrhage, bronchopulmonary dysplasia,
or necrotizing enterocolitis.
Our study aimed to prospectively analyze a cohort of
patients with an adequate number of VLBW infants to
determine if the proportion of postnatal WG is a risk factor
for ROP development. After logistic regression, our results
showed that WG proportion lower than 51.2%, according to
the ROC curve, was an independent risk factor for severe
ROP development. Furthermore, our study showed that all
of the three variables related to the WG (weight at 6 weeks
of life, absolute WG, and WG proportion from birth to
6 weeks of life) achieved statistical significance after
univariate analysis. The area under the ROC curve in our
study was 0.63 (95%CI: 0.495-0.761; P=0.037). For the
discriminative cutoff of 51.2% of the WG proportion,
sensitivity and specificity values were 66.3% and 62.6%
respectively. Positive and negative predictive values were
10.2% and 94.7% respectively, thus meaning that a preterm
who has gained more than 51.2% of weight proportional to
his BW, at the end of the sixth week of life, has around
94.7% chance of not developing severe ROP.
Conclusions
Our results have clinical importance because low WG, as
defined and measured at the end of 6 weeks of life, was an
easy identifiable risk factor, and helpful for predicting
severe ROP some weeks in advance of the development of
treatable ROP. In this way, ophthalmologists and neo-
natologists should take special care, and pay attention to
this group of patients during the screening for ROP. There
is a need for more studies assessing improvements in
nutrition among VLBW preterm babies at risk for ROP to
better understand this factor in ROP development.
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